List of bibliographic references indexed by Anticorps monoclonaux humanisés
Number of relevant bibliographic references: 15.
| Ident. | Authors (with country if any) | Title |
|---|
| 000043 (2020) |
Thierry Conrozier [France] ; Anne Lohse [France] ; Jean-Charles Balblanc [France] ; Pascale Dussert [France] ; Pierre-Yves Royer [France] ; Marie Bossert [France] ; Ana-Maria Bozgan [France] ; Vincent Gendrin [France] ; Aline Charpentier [France] ; Lynda Toko [France] ; Julio Badie [France] ; Chaouki Mezher [France] ; Marie-Françoise Roux [France] ; Ndri Juliette Kadiane-Oussou [France] ; Rémy Contreras [France] ; Julie Kessler [France] ; Isabelle Mazurier [France] ; Timothée Klopfenstein [France] ; Souheil Zayet [France] | Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration. |
| 000349 (2020) |
J-M Michot [France] ; L. Albiges ; N. Chaput ; V. Saada ; F. Pommeret ; F. Griscelli ; C. Balleyguier ; B. Besse ; A. Marabelle ; F. Netzer [France] ; M. Merad ; C. Robert ; F. Barlesi ; B. Gachot [France] ; A. Stoclin [France] | Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. |
| 000350 (2020) |
T. Klopfenstein [France] ; S. Zayet [France] ; A. Lohse [France] ; J-C Balblanc [France] ; J. Badie [France] ; P-Y Royer [France] ; L. Toko [France] ; C. Mezher [France] ; N J Kadiane-Oussou [France] ; M. Bossert [France] ; A-M Bozgan [France] ; A. Charpentier [France] ; M-F Roux [France] ; R. Contreras [France] ; I. Mazurier [France] ; P. Dussert [France] ; V. Gendrin [France] ; T. Conrozier [France] | Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. |
| 000352 (2020) |
Stanislas Faguer ; Arnaud Del Bello ; Florence Abravanel ; Marie-Laure Nicolau-Travers ; Nassim Kamar | Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19. |
| 000354 (2020) |
Kevin L. Winthrop [États-Unis] ; Xavier Mariette [France] | To immunosuppress: whom, when and how? That is the question with COVID-19. |
| 000524 (2020) |
Marco Matucci-Cerinic [Italie] ; Cosimo Bruni [Italie] ; Yannick Allanore [France] ; Massimo Clementi [Italie] ; Lorenzo Dagna [Italie] ; Nemanja S. Damjanov [Serbie] ; Amato De Paulis [Italie] ; Christopher P. Denton [Royaume-Uni] ; Oliver Distler [Suisse] ; David Fox [États-Unis] ; Daniel E. Furst [Italie, États-Unis] ; Dinesh Khanna [États-Unis] ; Thomas Krieg [Allemagne] ; Masataka Kuwana [Japon] ; Eun Bong Lee [Corée du Sud] ; Mengtao Li [République populaire de Chine] ; Shiv Pillai [États-Unis] ; Yukai Wang [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Gloria Taliani [Italie] | Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. |
| 000776 (2020) |
Alan G. Fraser [Royaume-Uni, Belgique] ; Piotr Szyma Ski [Pologne] ; Elizabeth Macintyre [France] ; Martin Landray [Royaume-Uni] | Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? |
| 000807 (2020) |
Gabriela Gautier-Vargas [France] ; Clement Baldacini [France] ; Ilies Benotmane [France] ; Nicolas Keller [France] ; Peggy Perrin [France] ; Bruno Moulin [France] ; Sophie Caillard [France] | Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. |
| 000810 (2020) |
Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean-François Deux [France] ; Martin Colard [France] ; Anne-Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France] | Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab. |
| 000950 (2020) |
Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France] | Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions. |
| 000972 (2020) |
C. Louapre [France] ; E. Maillart [France] ; T. Roux [France] ; V. Pourcher [France] ; G. Bussone [France] ; C. Lubetzki [France] ; C. Papeix [France] | Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum. |
| 001110 (2020) |
Marie-Hélène Odièvre [France] ; Charles De Marcellus [France] ; Hubert Ducou Le Pointe [France] ; Slimane Allali [France] ; Anne-Sophie Romain [France] ; Jenny Youn [France] ; Jessica Taytard [France] ; Nadia Nathan [France] ; Harriet Corvol [France] | Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome. |
| 001203 (2020) |
Roch Houot [États-Unis] ; Ronald Levy [États-Unis] ; Guillaume Cartron [France] ; Philippe Armand [États-Unis] | Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine? |
| 001695 (2020) |
Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France] | Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use? |
| 001854 (2020) |
Keisha Smith [États-Unis] ; Amy Pace [États-Unis] ; Stephan Ortiz [États-Unis] ; Shamsah Kazani [États-Unis] ; Scott Rottinghaus [États-Unis] | A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Anticorps monoclonaux humanisés"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i \
-Sk "Anticorps monoclonaux humanisés" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= MeshFr.i
|clé= Anticorps monoclonaux humanisés
}}
| This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021 |  |
